Nonstructural protein NS1 immunodominant epitope detected specifically in dengue virus infected material by a SELDI-TOF/MS based assay

Journal of Medical Virology

Volumn 84, Issue 3, 2012, Pages 490-499

  Steidel, Marine ^a   Fragnoud, Romain ^a   Guillotte, Michelle ^a   Roesch, Céline ^a   Michel, Sandrine ^a   Meunier, Thomas ^a   Paranhos Baccalà, Glàucia ^b   Gervasi, Gaspard ^a   Bedin, Frederic ^a  

^a BIOMÉRIEUX   (France)

^b Emerging Pathogens Laboratory   (France)

Author keywords

Dengue virus; NS1; SELDI TOF; Severe dengue

Indexed keywords

MONOCLONAL ANTIBODY; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 1 MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; EPITOPE MAPPING; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; SCHOOL CHILD; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADOLESCENT; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; CHILD; CHILD, PRESCHOOL; DENGUE; DENGUE VIRUS; EPITOPE MAPPING; FEMALE; HEK293 CELLS; HUMANS; IMMUNODOMINANT EPITOPES; INFANT; MALE; MOLECULAR SEQUENCE DATA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VERO CELLS; VIRAL NONSTRUCTURAL PROTEINS;

DENGUE VIRUS;

EID: 84855902834     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23204     Document Type: Article

References (49)

1. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M. 2002. Enzyme-linked immunosorbant assay specific to dengue virus type 1 NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infection. J Clin Microb 40: 376-381.
2. Alcon-LePoder S, Drouet MT, Roux P, Frenkiel MP, Arborio M, Durand-Schneider AM, Maurice M, Le Blanc I, Gruenberg J, Flamand M. 2005. The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: Implications for viral infectivity. J Virol 79: 11403-11411.
3. Ashok MS, Rangarajan PN. 2002. Protective efficacy of a plasmid DNA encoding JEV envelope protein fused to tissue plasminogen activator signal sequence: Studies in a murine intracerebral virus challenge model. Vaccine 20: 1563-1570.
4. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, Jairungsri A, Kanlaya R, Tangthawornchaikul N, Puttikhunt C, Pattanakitsakul SN, Yenchitsomanus PT, Mongkolsapaya J, Kasinrerk W, Sittisombut N, Husmann M, Blettner M, Vasanawathana S, Bhakdi S, Malasit P. 2006. Vascular leakage in severe dengue virus infections: A potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 193: 1078-1088.
5. Avirutnan P, Zhang L, Punyadee N, Manuyakorn A, Puttikhunt C, Kasinrerk W. 2007. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog 3: e183.
6. Avirutnan P, Hauhart RE, Somnuke P, Blom AM, Diamond MS, Atkinson JP. 2011. Binding of Flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J Immunol 187: 424-433.
7. Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, Johnson S, Diamond MS, Beatty PR, Harris E. 2010. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 6: e1000790.
8. Bedin F. 2007. Bresil, land of choice for arbovirosis? Med Trop 67: 281-287.
9. Byron EM, Koraka P, Osterhaus ADME. 2009. Dengue virus pathogenesis: An integrated view. Clin Microbiol Rev 22: 564-581.
10. Chen MC, Lin CF, Lei HY, Lin SC, Liu HS, Yeh TM, Anderson R, Lin YS. 2009. Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency. J Immunol 183: 1797-1803.
11. Chen Y, Yuxian P, Yonghui G, Liwen Q, Xixia D, Xiaoyan C. 2010. Comprehensive mapping of immunodominant and conserved serotype- and group-specific B-cell epitopes of nonstructural protein 1 from dengue virus type 1. Virology 398: 290-298.
12. Desiderio C, Rossetti DV, Lavarone F, Messana I, Castagnola M. 2010. Capillary electrophoresis-mass spectrometry: Recent trends in clinical proteomics. J Pharm Biomed Anal 15: 1161-1169.
13. Dussart P, Labeau B, Lagathu G, Louis P, Nunes MR, Rodrigues SG. 2006. Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum. Clin Vacc Immunol 13: 1185-1189.
14. Eriksson J, Woschnagg C, Fernvik E, Venge P. 2007. A SELDI-TOF MS study of the genetic and post-translational molecular heterogeneity of eosinophil cationic protein. J Leukoc Biol 82: 1491-1500.
15. Falconar AKL, Young PR. 1991. Production of dimer specific and dengue virus group cross reactive mouse monoclonal antibodies to the dengue 2 virus non-structural protein NS1. J Gen Virol 72: 961-965.
16. Flamand M, Megret F, Mathieu M, Lepault J, Rey FA, Deubel V. 1999. Dengue virus type 1 NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol 73: 6104-6110.
17. Frank R, Döring R. 1988. Simultaneous multiple peptide synthesis under continuous flow conditions on cellulose paper discs as segmental solid synthesis. Tetrahedron 44: 6031-6040.
18. Fried JR, Gibbons R, Kalayanarooj V, Thomas S, Srikiatkhachorn SJ, Yoon A, Jarman IK, Green RG, Rothman S, Cummings DAT. 2010. Serotype-specific differences in the risk of dengue hemorrhagic fever: An analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis 4: e617.
19. Gutsche I, Coulibaly F, Voss JE, Salmon J, Alayer J, Ermonval M, Larquet E, Charneau P, Krey T, Mégret F, Guittet E, Rey FA, Flamand M. 2011. Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein. PNAS 108: 8003-8008.
20. Halstead SB, O'Rourke EJ. 1977. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265: 739-741.
21. Hodgett A, Levin M, Kroll JS, Langford PR. 2007. Biomarker discovery in infectious disease using SELDI. Future Microbiol 2: 35-49.
22. Imrie A, Roche C, Zhao Z, Bennett S, Laille M, Effler P, Cao-Lormeau VM. 2010. Homology of complete genome sequences for dengue virus type-1, from dengue fever- and dengue-haemorrhagic-fever-associated epidemics in Hawaï and French Polynesia. Ann Trop Med Parasitol 104: 225-235.
23. Issaq HJ, Veenstra TD, Conrads TP, Felschow D. 2002. The SELDI-TOF MS approach to proteomics: Protein profiling and biomarker identification. Biochem Biophys Res Commun 292: 587-592.
24. Jolivet-Reynaud C, Dalbon P, Viola F, Yvon S, Paranhos-Baccala G, Piga N, Bridon L, Trabaud MA, Battail N, Sibai G, Jolivet M. 1998. HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: Characterization of major epitopes useful for antigen detection. J Med Virol 56: 300-309.
25. Kittigul L, Pitakarnjanakul P, Sujirarat D, Siripanichgon K. 2007. The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection. J Clin Virol 39: 76-81.
26. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Rothman AL, Livingston PG, Janus J, Ennis FA. 1990. Human immune responses to dengue virus. Southeast Asian J Trop Med Public Health 21: 658-662.
27. Kurosu T, Chaichana P, Yamate M, Anantapreecha S, Ikuta K. 2007. Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1. Biochem Biophys Res Commun 362: 1051-1056.
28. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. 2002. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 186: 1165-1168.
29. Lin CF, Chiu SC, Hsiao YL, Wan SW, Lei HY, Shiau AL, Liu HS, Yeh TM, Chen SH, Liu CC, Lin YS. 2005. Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol 174: 395-403.
30. Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U. 2003. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 68: 191-202.
31. Noisakran S, Dechtawewat T, Rinkaewkan P, Puttikhunt C, Kanjanahaluethai A, Kasinrerk W, Sittisombut N, Malasit P. 2007. Characterization of dengue virus NS1 stably expressed in 293T cell lines. J Virol Methods 142: 67-80.
32. Pandey BD, Igarashi J. 2000. Severity-related molecular differences among nineteen strains of dengue type 2 viruses. Microbiol Immunol 44: 179-188.
33. Perera R, Kuhn RJ. 2008. Structural proteomics of dengue virus. Curr Opin Microbiol 11: 369-377.
34. Pryor MJ, Wright PJ. 1993. The effect of site directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus. Virology 194: 769-780.
35. Puttikhunt C, Prommool T, U-Thainual N, Ong-Ajchaowlerd P, Yoosook K, Tawilert C, Duangchinda T, Jairangsri A, Tangthawornchaikul N, Malasit P, Kasinrerk W. 2011. The development of a novel serotyping-NS1-ELISA to identify serotypes of dengue virus. J Clin Virol 50: 314-319.
36. Qiu LW, Di B, Wen K, Wang XS, Liang WH, Wang YD, Pan YX, Wang M, Ding YQ, Che XY. 2009. Development of an antigen capture immunoassay based on monoclonal antibodies specific for dengue virus serotype 2 nonstructural protein 1 for early and rapid identification of dengue virus serotype 2 infections. Clin Vaccine Immunol 16: 88-95.
37. Rico-Hesse R. 2003. Microevolution and virulence of dengue viruses. Adv Virus Res 59: 315-341.
38. r technology in proteomic research. Pathol Res Pract 200: 83-94.
39. Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, Chien LJ, Chin C, Yang HH, Lin TH, Huang JH. 2002. Potential application of nonstructural protein NS1 serotype-specific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study of dengue virus infection: Correlation of results with those of the plaque reduction neutralization test. J Clin Microbiol 40: 1840-1844.
40. Sun DS, King CC, Huang HS, Shih YL, Lee CC, Tsai WJ, Yu CC, Chang HH. 2007. Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. J Thromb Haemost 5: 2291-2299.
41. Thein S, Aung MM, Shwe TN, Aye M, Zaw A. 1997. Risk factors in dengue shock syndrome. Am J Trop Med Hyg 56: 566-572.
42. Thomas L, Verlaeten O, Cabié A, Kaidomar S, Moravie V, Martial J, Najioullah F, Plumelle Y, Fonteau C, Dussart P, Césaire R. 2008. Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic. Am J Trop Med Hyg 78: 990-998.
43. Varki A, Cummings R, Esko J, Freeze H, Hart G, Marth J. 1999. Essentials of glycobiology. New York: CSHL Press.
44. Vaughan K, Greenbaum J, Blythe M, Peters B, Sette A. 2010. Meta-analysis of all immune epitope data in the Flavivirus genus: Inventory of current immune epitope data status in the context of virus immunity and immunopathology. Viral Immunol 23: 259-284.
45. Wallis TP, Huang CY, Nimkar SB, Young PR, Gorman JJ. 2004. Determination of the disulfide bond arrangement of dengue virus NS1 protein. J Biol Chem 279: 20729-20741.
46. Walther TC, Mann M. 2010. Mass spectrometry-based proteomics in cell biology. J Cell Biol 190: 491-500.
47. WHO. Library cataloguing-in-publication data. Dengue: Guidelines for diagnosis, treatment, prevention and control, 2009.
48. Wrinkler G, Randolph VB, Cleaves GR, Ryan TE, Stollar V. 1988. Evidence that the mature form of the flavivirus non-structural protein NS1 is a dimmer. Virology 162: 187-196.
49. Young PR, Hilditch PA, Bletchly C, Halloran W. 2000. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 38: 1053-1057.